- Filed
- May 9, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 3, 2024 | 51.41M sh |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $60.41M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $59.78M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $303.61M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $310.13M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $212.84M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $237.77M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $511.05M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $565.43M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $0 |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $641K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $74.96M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $193.63M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 43.47M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $6.08M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$49.09M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $401.32M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $310.47M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$1.08 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$1.08 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $20.72M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $68.25M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$47.02M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$51.71M |
| Revenue | Q1 2024 · Mar 31, 2023 | $41.62M |